Technohal
Guest staff

prof.dr. W.H. van Harten (Wim)

Professor Quality Management and Health Care Technology
BMS-TPS-HTSR
Technohal 3105
w.h.vanharten@utwente.nl
+31534894429
Visitekaartje

Wim H. van Harten graduated as M.D. and specialized in tropical medicine. On returning from Africa he focused on public health and health administration. He obtained a degree in community medicine/public and worked Chief Medical Advisor of a major health insurance company (1986-1992). Thereafter worked  as CEO at t the rehabilitation hospital “Het Roessingh” in Enschede and as member of the Executive Board of the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL). From 2005 onwards  he was  appointed as Research Group leader at the Division of Psychosocial Research and Epidemiology at the NKI.

 

Since 2001 he is part-time professor on “Quality Management and Health Care Technology” at the department of Health Technology and Services Research of the School of Management and Governance. So far, he supervised over 15 Ph.D graduations and presently his group consists of 3 postdocs and 7 PhD students in the NKI and 4 in other universities. He published over 190 peer reviewed papers on health services and quality management, especially  Health Technology Assessment, E-health and Process improvement.

 

He served as President of the OECI from 2011-2014, presently as Chair OECI Working Group on Health Economics and member of the OECI Cancer Center Accreditation and Designation Board. From 2008 – 2014 he served as Board member of the Netherlands Hospital Association with the portfolio of innovation, drug costs and quality issues.

 

From 2015 he is CEO of Rijnstate (general) Hospital in Arnhem, a large teaching hospital with an annual expenditure of € 560 million and around 5500 employees, of whom around 300 medical specialists and 110 MDs in specialist training. He is Chair of mProve, a collaborative of 7 large teaching hospitals in the Netherlands with a total annual expenditure of ± € 3 billion.  

Expertises

  • Medicine and Dentistry

    • Patient
    • Health Care Cost
    • Cost-Effectiveness Analysis
    • Malignant Neoplasm
    • Breast Cancer
    • Hospital
    • Therapeutic Procedure
    • Technology Assessment

Organisaties

Publicaties

2026

Rationales for Prehabilitation Programs in Patients Preparing for Oncologic Surgery: A Systematic Review (2026)Annals of surgical oncology, 2026(1), 1. van Harten, W. H.

2025

Hospital-based real-world evidence in health technology assessment: Insights from a scoping review of European, Australian and North American guidance and expert interviews (2025)BMJ open, 15. Article e100304. Al-Khayat, Z., Franzen, N., Retèl, V. P. & Van Harten, W. H.https://doi.org/10.1136/bmjopen-2025-100304Device based monitoring in digital care and its impact on hospital service use (2025)npj Digital Medicine, 8(1). Article 16. Jansen, A. J. S., Peters, G. M., Kooij, L., Doggen, C. J. M. & van Harten, W. H.https://doi.org/10.1038/s41746-024-01427-8Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population (2025)JAMA network open, 8(12), e2548538. van Schaik, L. F., Maes, B., Volders, P. J., Froyen, G., Aftimos, P., de Azambuja, E., Blommestein, H. M., van Harten, W. H. & Retèl, V. P.https://doi.org/10.1001/jamanetworkopen.2025.48538Quality and safety management of advanced medical technologies in home care organisations in the Netherlands: a qualitative survey at the tactical level (2025)BMJ open, 15(12), e101968. Article e101968. Ten Haken, I., Ben Allouch, S. & van Harten, W. H.https://doi.org/10.1136/bmjopen-2025-101968Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial (2025)Annals of oncology, 36(10), 1154-1165. ten Ham, R. M. T., Rohaan, M. W., Egeler, M., Menezes, R., Holz Borch, T., Kessels, R., Jedema, I., Nuijen, B., Nijenhuis, C. M., van de Poll-Franse, L. V., Geukes Foppen, M. H., Lindenberg, M., Mansfield Noringriis, I., Monberg, T. J., Donia, M., van Harten, W., Svane, I. M., Haanen, J. B. A. G. & Retèl, V. P.https://doi.org/10.1016/j.annonc.2025.06.005Socioeconomic impact among and socioeconomic support services for adolescents and young adults with cancer: A European perspective (2025)International journal of cancer, 157(7), 1433-1445. Vancoppenolle, J. M., Janssen, S. H. M., Franzen, N., van der Graaf, W. T. A., Retel, V., Husson, O. & van Harten, W.https://doi.org/10.1002/ijc.35488Exercise effects on symptoms of depression and anxiety vary by patient, clinical, and intervention characteristics in cancer survivors: Results from pooled analyses of individual participant data of 26 RCTs (2025)Supportive care in cancer, 33(7). Article 647. Kenkhuis, M. F., Doorenbos, M., Mast, I. H., Aaronson, N. K., van Beurden, M., Bohus, M., Courneya, K. S., Daley, A. J., Galvão, D. A., Goedendorp, M. M., van Harten, W. H., Hayes, S. C., Hiensch, A. E., Irwin, M. L., Kersten, M. J., Knoop, H., May, A. M., McConnachie, A., van Mechelen, W., … Buffart, L. M.https://doi.org/10.1007/s00520-025-09646-9Accessibility to cancer medicines in Europe: Towards equitable access and fair pricing (2025)[Thesis › PhD Thesis - Research UT, graduation UT]. University of Twente. Vancoppenolle, J. M. J.https://doi.org/10.3990/1.9789036565806Financial toxicity and socioeconomic impact of cancer in Europe (2025)ESMO Open, 10(6). Article 105293. Vancoppenolle, J., Franzen, N., Azarang, L., Juslin, T., Krini, M., Lubbers, T., Mattson, J., Mayeur, D., Menezes, R., Schmitt, J., Scotte, F., Seoane López, O., Skaali, T., Ubels, J., Schlander, M., Retel, V. & van Harten, W. H.https://doi.org/10.1016/j.esmoop.2025.105293

Onderzoeksprofielen

Vakken collegejaar 2025/2026

Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.

Vakken collegejaar 2024/2025

Scan de QR-code of
Download vCard